Employees
~50
Stage
Commercial
Modalities
Molecular diagnostics

Wren Laboratories General Information

Offers CAP/CLIA certified liquid biopsy mRNA diagnostic tests including NETest for neuroendocrine tumors and PROSTest for prostate cancer. Uses machine learning and multi-gene mRNA expression analysis.

Contact Information

Website
Primary Industry
Diagnostics
Corporate Office
Branford, Connecticut
United States

Drug Pipeline

NETest 2.0
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to Wren Laboratories's pipeline data

Book a demo

Key Partnerships

Yale University

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Wren Laboratories Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Wren Laboratories's complete valuation and funding history, request access »